Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

• Status: Completed
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of this study is to evaluate the effectiveness in pediatric subjects of three different strengths of resiquimod gel applied to common wart(s) three times a week for four weeks.

A second purpose is to evaluate the safety of the drug.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Graceway Pharmaceuticals, LLC

Criteria

Inclusion Criteria:

• Diagnosis of common warts

• Ages between 3 to 11

Exclusion Criteria:

• Other types of wart(s), ie. plantar

• Currently participating in another clinical study

• Chronic viral hepatitis B or C